AstraZeneca
AZN
AZN
1,402 hedge funds and large institutions have $45.2B invested in AstraZeneca in 2025 Q4 according to their latest regulatory filings, with 264 funds opening new positions, 499 increasing their positions, 410 reducing their positions, and 119 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
9% more funds holding
Funds holding: 1,284 → 1,402 (+118)
5% more funds holding in top 10
Funds holding in top 10: 21 → 22 (+1)
0.08% less ownership
Funds ownership: 15.92% → 15.84% (-0.08%)
Holders
1,402
Holding in Top 10
22
Calls
$597M
Puts
$420M
Top Buyers
| 1 | +$420M | |
| 2 | +$412M | |
| 3 | +$327M | |
| 4 |
Citigroup
New York
|
+$204M |
| 5 |
Barclays
London,
United Kingdom
|
+$180M |
Top Sellers
| 1 | -$924M | |
| 2 | -$831M | |
| 3 | -$550M | |
| 4 |
Primecap Management
Pasadena,
California
|
-$258M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$241M |
